MedTrace Logo

Evaluation of a Blood Potassium Measurement Device From Capillary Samples (ALPHA)

NCT04907773 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2021-11-01

No results posted yet for this study

Summary

This is an open, prospective, and interventional study investigating the potassium measurement with the CardioRenal device in capillary blood. It will be conducted at one investigational site.

Each subject will have capillary blood collections. Additionally as a reference a venous blood collection will be conducted

Conditions

  • Potassium Measurement

Interventions

OTHER

Capillary blood sampling

Each subject will have one to two capillary blood collections.

OTHER

Venous blood sampling

Each healthy subject will also have a reference venous blood collection.

OTHER

Arterio-venous blood sampling

Each hemodialysed subject will also have a reference arterio-venous blood collection.

Sponsors & Collaborators

  • CardioRenal

    lead INDUSTRY

Principal Investigators

  • Damien Gruson, Prof · Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2021-10-15
Completion
2021-10-15

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04907773 on ClinicalTrials.gov